(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HIKMA.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HIKMA.

ST13

US500000088720317

Class

5

Filing

88720317

Registration

6634245

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

51

Latest update

11/26/2024

Trademark type

Combined

Nice classes

5

Filing date

12/09/2019

Registration date

02/01/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/01/2022

Last transaction

11/26/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/09/2018

First use in commerce

11/09/2018

Drawing code

5

Owner type

99

Owner location

London, GB

Examiner

LEE RISO, LOKSYE

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of "HIKMA." in stylized script.

Holders and representatives

Holders

HIKMA PHARMACEUTICALS PLC

Representatives

Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medicinal preparations and substancessystemic anti-infectivespharmaceutical and medicinal substances for the preventioncuringtreatment of viralmetabolicalimentaryendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalparasiticpsychiatricimmune system related diseases and disorders; pharmaceutical and medicinal substances for the preventioncuringtreatment of allergiesinflammationpaininfectious diseasesblood diseases and disordersnervous system diseases and disordersmalignant neoplastic diseases and disordersimmunomodulating agent diseases and disorders; chemical preparations for pharmaceutical or medical purposesfor viralmetabolicalimentaryendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalparasiticpsychiatricimmune system related diseases and disordersallergiesinflammationpaininfectious diseasesblood diseases and disordersnervous system diseases and disordersmalignant neoplastic diseases and disordersimmunomodulating agent diseases and disorders

Publications

History of USPTO decisions and trademark events.

51 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/26/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/26/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/01/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/29/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/28/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/21/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/17/2021

IUAF

USE AMENDMENT FILED

11/23/2021

EISU

TEAS STATEMENT OF USE RECEIVED

11/23/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/16/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/16/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/16/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/16/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/16/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/25/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/30/2021

PUBO

PUBLISHED FOR OPPOSITION

03/30/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/10/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/02/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/02/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/02/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/22/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

02/22/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/22/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

02/22/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/22/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/04/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

02/04/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/12/2020

GNFR

FINAL REFUSAL E-MAILED

08/12/2020

CNFR

FINAL REFUSAL WRITTEN

08/12/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/20/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/20/2020

ALIE

ASSIGNED TO LIE

07/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/30/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/30/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/30/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/30/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/30/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/30/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/30/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/30/2019

GNRT

NON-FINAL ACTION E-MAILED

12/30/2019

CNRT

NON-FINAL ACTION WRITTEN

12/30/2019

DOCK

ASSIGNED TO EXAMINER

12/26/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/12/2019

NWAP

NEW APPLICATION ENTERED

12/12/2019

Continuous trademark protection

Get notified about every new filing that threatens HIKMA. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.